Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.

Abstract	We previously reported that patients with lung adenocarcinomas with KRAS gene mutations and strong proliferating activity had poorer outcomes, even in the early stage of the disease. The aim of the present study was to elucidate the potential molecular basis of these highly malignant lung tumors by focusing on S100 proteins (S100A2, S100A7, and S100A11), which are downstream targets of oncogenic KRAS and promoters of tumor progression. The immunohistochemical expression of S100 proteins was examined in 179 primary lung adenocarcinomas, and the potential relationships between their levels and clinicopathologic factors were analyzed. Among the three subtypes, S100A11 levels were significantly higher in adenocarcinomas with KRAS mutations and strong proliferating activity. They were also higher in adenocarcinomas with poorly differentiated tumors. Furthermore, higher levels of S100A11 were associated with shorter disease-free survival. These results suggest that the up-regulation of S100A11 plays a role in tumor progression, particularly in KRAS-mutated lung adenocarcinomas.
Authors	Tetsukan Woo, Koji Okudela, Hideaki Mitsui, Michihiko Tajiri, Yasushi Rino, Kenichi Ohashi, Munetaka Masuda
Journal	PloS one (PLoS One) Vol. 10 Issue 11 Pg. e0142642 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID	26544866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	KRAS protein, human S100 Proteins S100A11 protein, human Proto-Oncogene Proteins p21(ras)
Topics	Adenocarcinoma (genetics, metabolism, pathology) Adenocarcinoma of Lung Aged Cell Differentiation Cell Proliferation Disease Progression Disease-Free Survival Female Humans Immunohistochemistry Kaplan-Meier Estimate Lung Neoplasms (genetics, metabolism, pathology) Male Middle Aged Mutation Proto-Oncogene Proteins p21(ras) (genetics) S100 Proteins (metabolism) Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!